Evidence map›Paper›PMID 28874953›Full record

ArticleOxidative medicine and cellular longevity2017

Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production.

Alena Pecinova, Zdenek Drahota, Jana Kovalcikova, Nikola Kovarova, Petr Pecina, Lukas Alan, Michal Zima, Josef Houstek, Tomas Mracek

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Effects of Biguanide-PROTACs in Pancreatic Cancer Cells.Molecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alena PecinovaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Zdenek DrahotaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Jana KovalcikovaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Nikola KovarovaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Petr PecinaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Lukas AlanInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Michal ZimaInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Josef HoustekInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.
Tomas MracekInstitute of Physiology of the Czech Academy of Sciences, Vídeňská, 1083 Prague, Czech Republic.ORCID 0000-0002-9492-0718
Czech Academy of Sciences · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metformin is widely prescribed as a first-choice antihyperglycemic drug for treatment of type 2 diabetes mellitus, and recent epidemiological studies showed its utility also in cancer therapy. Although it is in use since the 1970s, its molecular target, either for antihyperglycemic or antineoplastic action, remains elusive. However, the body of the research on metformin effect oscillates around mitochondrial metabolism, including the function of oxidative phosphorylation (OXPHOS) apparatus. In this study, we focused on direct inhibitory mechanism of biguanides (metformin and phenformin) on OXPHOS complexes and its functional impact, using the model of isolated brown adipose tissue mitochondria. We demonstrate that biguanides nonspecifically target the activities of all respiratory chain dehydrogenases (mitochondrial NADH, succinate, and glycerophosphate dehydrogenases), but only at very high concentrations (10

Indexed as

Adipose Tissue, BrownAnimalsBiguanidesGlycerolphosphate DehydrogenaseHydrogen PeroxideHypoglycemic AgentsMembrane Potential, MitochondrialMetforminMitochondriaOxidation-ReductionPhenforminRatsRats, WistarReactive Oxygen SpeciesSuccinic AcidBiguanidesGlycerolphosphate DehydrogenaseHydrogen PeroxideHypoglycemic AgentsMetforminPhenforminReactive Oxygen SpeciesSuccinic Acid

Identifiers

PMID28874953
PMCPMC5569935
OpenAlexW2742928337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.